SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " utica " 445 found 🔀 AI-powered Shuffle
Health Canada recognises Saccharomyces cerevisiae as a source of resveratrol and yeast beta-glucan
Regulatory update supports the development and licensing of fermentation-derived health ingredients in Canada
Watch the USC Price School's nautical science class voyage to Catalina Island
The USC Price School is home to a unique nautical science program that teaches students navigation and seamanship.
Nellson Nutraceutical LLC names VP, quality and regulatory
Raj Krishnamachari rejoins the company and is succeeding Marty Hudak-Roos.
Syneos Health and Tufts CSDD Study Shows Clinical Trial Performance Depends More on Operating Model Design Than Sourcing Strategy
Data From 13 Leading Pharmaceutical Companies Points to Execution, Governance and Partner Coordination as Key Drivers of Trial PerformanceMORRISVILLE, N.C., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Syneos Health®, a leading fully integrated biopharmaceutical solutions organization, today announced findings from a first-of-its-kind benchmarking study conducted by the Tufts Center for the Study of Drug Development. The research examined one of the industry’s most persistent questions: does the sourcing
New York launches measles dashboard as cases rise statewide
The New York State Department of Health launched a new measles dashboard that tracks cases by county and date
DHL inks health care logistics deals in South America
Parcel giants have been investing in health care and pharmaceutical shipping, among their most lucrative lines of business.
Three UConn School of Pharmacy Alumni will be recognized at the 2026 UConn School of Pharmacy & Pharmaceutical Sciences Alumni Awards
The 2026 UConn School of Pharmacy & Pharmaceutical Sciences Alumni Awards take place on Saturday, September 19, where three alumni will be recognized fo ...
AbbVie named Official Pharmaceutical Sponsor of PGA TOUR, 2026 Presidents Cup; launches Birdies for Brain Health campaign
NORTH CHICAGO, Ill.– AbbVie (NYSE: ABBV), a global pharmaceutical leader, and the PGA TOUR announced Tuesday a partnership naming AbbVie the Official Pharmaceut
Novo Nordisk (CPSE:NOVO B) Rebrands As Novo In Consumer Health Push
Novo Nordisk (CPSE:NOVO B) has rebranded to "Novo" as part of a shift toward a more consumer-focused healthcare identity. The group is introducing a new corporate culture intended to support its obesity and diabetes franchises in increasingly crowded markets. Management positions the rebrand as a move beyond traditional pharmaceuticals, with a broader focus on consumer-facing health solutions. The shift to the Novo identity reworks how the business presents itself to obesity drug users and...
Utica Maennerchor Hosts 1st Outdoor Oktoberfest September 19
The Utica Maennerchor will hold its first outdoor Oktoberfest celebration with German food, beer and music.
BioMarin appoints Robert Plenge to its Board and Science & Technology Committee
BioMarin appointed Robert Plenge, M.D., Ph.D., to its Board of Directors and to the Science and Technology Committee, effective September 10, 2026.Original SEC Filing: BIOMARIN PHARMACEUTICAL INC [ BMRN ] - 8-K - Sep. 14, 2026This is an AI-powered summary. It may contain inaccuracies. Consider veri…
What supplement formulators can borrow from pharmaceutical delivery science
Poor absorption is a problem the pharmaceutical industry solved decades before most supplement formulators had to think about it. Compounds that show real biological activity in a lab often perform far worse once they're inside the body, because getting a molecule to dissolve, cross the gut wall and reach circulation is a separate engineering problem from proving the molecule does something useful
Five Families Ensemble to perform at MVCC
Mohawk Valley Community College will host the Five Families Ensemble for a concert at Schafer Theater on its Utica campus, with tickets available online.
1983 Utica Blue Sox reunite at History Center
The Oneida County History Center will host a reunion of the 1983 Utica Blue Sox championship team, featuring players, stories and memorabilia.
GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports
GE HealthCare Technologies is in talks over a possible $1 billion deal to buy radiopharmaceutical developer Sofie Biosciences, the Financial Times reported on Sunday citing people familiar with the matter.
Munson sets Met simulcast season in Utica
Munson will present its 2026-27 Met: Live in HD season in Utica, beginning Sept. 19 with a program marking 20 years of Metropolitan Opera simulcasts.
Saranac Oktoberfest set for three weekends
Saranac Brewery will hold Oktoberfest over three weekends at its Utica biergarten, with food, games, competitions, keg taps and free admission.
Teen overcomes health challenges to harvest alligator
Zoe Pell, a 15-year-old from Utica, overcame a disease and partial paralysis to harvest a 12-foot, 4-inch alligator during a Southern Outdoors Unlimited hunt in Gautier in 2026.
On Display: 6th Annual Federated Garden Club Flower Show at Utica Public Library
The sixth annual Federated Garden Clubs District V Flower Show showcases vibrant floral designs and horticultural displays at the Utica Public Library.
Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units
* 500,000 contracted units of ROSARTIA annually / 2.5 million over five years through a new long-term agreement at wholly owned subsidiary Cana Laboratories * Expands Cosmos Health's manufacturing presence in cardiovascular pharmaceuticals, adding production of statin-based lipid-lowering therapies to Cana's growing contract manufacturing portfolio * Cumulative contract manufacturing orderbook increases to more than 27.
Eyewitness Sports Scoreboard for Friday, September 11
The first week of school is nearing its end, but high school and college soccer pitches are running full speed into the weekend and beyond! We had a full night on local pitches and football fields all over the Mohawk Valley, and you can catch up with all of it on the Friday edition of the Eyewitness Sports Scoreboard!
What Health Equity Champions Can Learn from Pharmaceutical Sales
The same mechanics can now help people meet new Medicaid work requirements or exemptions, increase referrals to evidence-based health interventions, and dramatically increase enrollment in vital programs that improve health outcomes and reduce inequities.
Eyewitness Sports Scoreboard for Thursday, September 10
As the first week of school comes to an end, the high school sports season goes into full swing!
Lilly’s GLP-1 Windfall to Fund Investments in Women’s Health
The pharmaceutical giant has been assembling experts and hunting for new medicines across conditions including bone health and endometriosis, sources told Bloomberg.
Utica University to screen 'Late Shift'
Utica University's Films on Thursday series will continue with a free screening of "Late Shift," a drama about nurse working in an understaffed hospital.
Natural Field expands NF TriSolve platform into sleep wellness with science-driven solutions
Natural Field announces the expansion of its NF TriSolve branded nutraceutical solution platform into the sleep wellness category with the introduction of NF TriSolve SleepRestore Complex
Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business
/PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces Faris El Refaie, a...
Project Fibonacci to celebrate 10 years with charity gala
The Project Fibonacci Foundation will celebrate a decade of curiosity, innovation, opportunity, and community impact with Tap Into STEAM: The Golden 10 on Sunday, September 13, at the Irish Cultural Center in Utica, according to organizers.
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
VANCOUVER, British Columbia, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (Nasdaq: OPTH) (CSE: OPTI) (“Optimi” or the “Company”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it will participate in the H.C. Wainwright 28th Annual Global Investment Conference. The conference will be held September 14-16, 2026, at the Lotte New York Palace Hotel. A Company presentation will be available on demand here beginning Friday, Septem
Business Aviation & AAM Appointments: Royal Aeronautical Society, Cutter Aviation, And More
Lindsey Oliver of BBGA is honored as a Royal Aeronautical Society fellow, while Cutter Aviation and Skyfarer announce key leadership appointments.
Bausch Health and YUN Announce Expansion to Mexico and Across Additional EMEA Markets
/PRNewswire/ -- Bausch Health Companies Inc. (NYSE: BHC)(TSX: BHC), a global, diversified pharmaceutical company, and YUN, a Belgian innovator in pioneering...
Natural Field Expands NF TriSolve® Platform Into Sleep Wellness With Science-Driven Nutraceutical Solutions
/PRNewswire/ -- Natural Field, a technology-driven nutraceutical ingredient solutions provider, announced the expansion of its NF TriSolve® branded...
Osaka has the science. Now it needs the business
Osaka is striving to turn world-class life sciences research into a global healthcare industry - testing whether Japan's pharma and biotech sector can finally scale internationally.
Osaka has the science. Now it needs the business
Osaka is striving to turn world-class life sciences research into a global healthcare industry - testing whether Japan's pharma and biotech sector can finally scale internationally.
Blaze destroys A340-300 centrepiece of Turkish aeronautical science park
Converted ex-Turkish Airlines airframe opened as interactive aviation technology exhibit less than a year ago.
Protein Pop launches 15 g protein and prebiotic soda for gut health
Rise Wellness has expanded its Protein Pop range with a zero-sugar sparkling beverage combining whey protein, collagen and five grams of fibre
Follow Ajna Husovic, Utica Academy of Science
Get the latest news, schedule, scores, stats, league standings, rankings and photos for high school sports teams and players.
15 discouraging hours with Onimusha: Way of the Sword, and 10 brilliant ones with He Who Watches
In the last few weeks, while playing some video games that I might review, I emailed two cries for help. I sent the first to a rep for Capcom, confessing that the company’s samurai game Onimusha Way of the Sword (out today for PC and console) was crushing me. “Feels like I’m playing ‘hard’ mode, not ‘normal,’” I wrote. “And I don’t want to have to knock it down to “story”. I’m exploring, trying to level my gear, but these two-phase boss fights with no mid-fight checkpoints are brutal.” I wagered I was only about halfway through the game, if that. I wasn’t sure I could keep up with the steepening difficulty curve. Was I missing something? Then, on Monday, I took some photos of some puzzles that were baffling me in the mind-bending He Who Watches (out now on PC), wrote out lengthy descriptions of how I’d been trying to solve them and asked Bobby Vanden, the game’s solo developer, for a nudge in the right direction. I told Vanden I’d spent hours on these puzzles. “I’m stuck in triplicate,” I told him. Could he tell me if the solutions I was attempting were even on the right track? I didn’t mention that the puzzles—coupled with major time pressures from other work—were stressing me out so much that playing the game was giving me headaches. This double dose of panic was unusual. I’m used to managing a workload full of reporting and reviewing, used to a crowded schedule and the need to stay calm amid the bustle. But I was stressed about these games. No one was forcing me to review them, nor even play them. I’d simply found them interesting enough to start, hoped they’d be interesting enough to write about and I’d sunk hours into them assuming I’d made the right call. Suddenly, however, I felt trapped. I was emailing for a way out. Above: This guy took me about an hour to beat. The feedback I got from Capcom confirmed my fears. They didn’t say it, but I will: Onimusha Way of the Sword is not for me. It’s a brutally hard game in need of a normal difficulty level. It’s a game that spikes so severely during its abundant boss fights—yet offers such flawed ways to improve when outside of them—that it feels like a bait-and-switch. In the new Onimusha, you play as famed samurai Musashi Miyamoto, aided by a magical soul-absorbing gauntlet that is possessed by a lady who offers advice. (Way of the Sword is a continuation of Capcom’s long-dormant Onimusha series, but that set-up had me wondering if the company was cribbing from their ill-fated Bionic Commando reboot; read about “wife-arm” when you get a chance). Way of the Sword is partially set in 17th century Kyoto, an explorable city where Miyamoto can fight demons, help civilians and eventually rescue ghostly dogs. The city evolves over time, with new mini adventures and obtainable loot on offer, all feeding into systems that promise to upgrade your gear and sword-fighting skills. Upgrades, however, are so incremental as to be imperceptible, causing the exploration of Kyoto to feel like inconsequential busywork. From that hub, players can go on linear missions into forests and old temples, where they will encounter many of the game’s tough bosses. Combat in Way of the Sword is akin to many modern melee games. Players are asked to mix attacks with dodges and parries. They’re encouraged to deplete an enemy’s stamina bar in order to do greater damage to its health bar. The old Onimusha games’ signature move was the issen, a counter-attack so sudden it’s all but pre-emptive. You strike just as they begin to strike toward you, beating them to the cut. By definition, the issen is a high risk move, leaving you wide open to pain. It feels risky in the game, especially against bosses, who can maul you in just a few blows. A game might train you to perform an issen well by offering a variety of lesser enemies who are not as tough as the boss but get close. Or it might offer a toehold against bosses by saving or checkpointing the player’s progress when a boss’ first health bar has been destroyed and before the second health bar appears. It might offer the less skilled player a chance to over-level their character, should the player simply commit to playing through its optional sidequests. Way of the Sword does none of this. Fighting its trivially easy grunt enemies and then its ferociously adept bosses is like playing a game of chess where I’ve got a rook, while the opposing side is all pawns and five queens. Bosses simply don’t checkpoint. You may be able to clear a boss’ first phase without taking much damage. Good for you. Do it again, every time you fail the second phase. As for the the central Kyoto hub, I kept pace with all of its added side activities and never felt like I was overpowered. Bosses could still easily buckle me. The new Onimusha, I concluded, is just too discouraging to keep playing. The advice I got from Capcom had been well-intentioned. They reminded me of the game’s various systems. They alerted me to an optional assist that flashes recommended button inputs (basically: counter this move; dodge that move). It was a little helpful. So was dropping down to “story mode,” which I tried last night. Story mode turns on those button prompts by default. It makes countering and dodging way too easy, nearly automatic. I don’t consider myself a master of action games like these, but I’ve cleared the likes of God of War, Stellar Blade, Star Wars Jedi and others of sub-Sekiro difficulty and had a fun time doing so. Not here. Not yet. Unless they patch Onimusha: Way of the Sword and add a middle difficulty or just checkpoint the damn bosses when they’re between health bars, my streak of loving Capcom games released in 2026 will likely end at two. It’s a shame, because I was having a good time finding those ghostly dogs. And then there’s He Who Watches, a phenomenal first person puzzle game with Portal vibes, except instead of a portal gun you’ve got a magical bow that shoots one arrow that can activate switches or be used to drag blocks. The twist is an actual twist: you can also walk on walls and the ceiling, reorienting gravity as you do, thereby placing blocks onto those other surfaces. Walking on walls and ceilings to solve problems is really the best thing. Would that I could in reality. He Who Watches consists of locked-room challenges, each brief enough to only require about a minute to actually solving, though it will take five, 10, eventually 30 minutes to figure out said solutions. They are not obvious! It’s a game of layered mechanics and shocking solutions. For example, see if you can follow this: You can drag a block to a wall. Then you can walk on the wall, which now feels like the floor, and drag that block across the wall. Later, back on the floor, you might realize you can look up. The block is still on the wall, stuck to it. You can shoot your magic arrow to its underside. Doing so creates a tether, so that you can yank the block off the wall and carry it, as if it were a balloon, into the spot where you need it to be to solve the puzzle. Here, watch Vanden explain some of the game’s basics in this launch trailer: As with any great puzzle game, the solutions to He Who Watches’ puzzles elicit relief and amazement. Oh my god, that worked! I didn’t even think that could be possible! Learning to solve the game’s puzzles feels like learning magic. But, oh, does the game get hard. Its Steam reviews, mostly glowing, are full of players remarking how quickly He Who Watches made them sweat. Wrote one: “loving this one already although my brain is hurting!” Wrote another: “As you get further in the game it feels like you need an IQ level of at least 120+.” Vanden has shown some mercy. Each locked room puzzle includes an optional junior version of the puzzle, meant to teach you. Difficulty nevertheless ramps severely. By the time I was emailing Vanden for help, I was struggling to even clear one of the hint puzzles. When I messaged him, my stress was exacerbated by strange things I’d found in the game’s various hubs: suspicious passageways, odd blocks and some intriguing locked doors. These were hints of secrets, I realized, yet I sensed I needed to play further into the game to understand them. I was stuck, but I wanted to see the rest. Vanden offered to give me the exact solutions, to solve those three puzzles for me, but first he gave four nudges. Three were for the specific puzzles, but his best hint was for all and ultimately proved to be a terrific life lesson: go back a bit, he suggested. Do the puzzles right before those. They were teaching you something. Focus on what their lesson was. Don’t rush, in other words. Recognize what you’ve accomplished. Build off of that. I did so. I absorbed the lessons. I saw those three tough puzzles in a new light. I solved one the night after he wrote back, another the morning after. I left a third for another time. I didn’t need it and I wanted to plunge deeper into the game, closer to the moment when I was sure I could start unlocking those secret doors. My head stopped hurting, too. He Who Watches feels special. It’s got more challenges, and I’m undeterred. It’s also nice that its puzzles don’t have a surprise second health bar. Game File is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Subscribe Item 2: In brief… 🎮 Ilari Kuittinen, co-founder of Helsinki-based Housemarque (Super Stardust HD, Resogun, Returnal) has stepped down from his studio, after a 31-year run, saying he’s “ taking a rare and well-deserved breather.” Sony purchased Housemarque in 2021, and the studio released its newest game, Saros, earlier this year. Trend-watch: Sony-owned Insomniac saw its founder Ted Price retire in early 2025, after a 30-year run. Sony-owned Sucker Punch saw its co-founder Brian Fleming step down in late 2025, after a 28-year run. 👀 Savvy Games Group chief Brian Ward is stepping down from the Saudi-government-backed games conglomerate, Bloomberg reports. No word on a long-term successor yet, nor if this augurs any closer integration between Savvy and Electronic Arts. EA was purchased by a consortium led by Saudi’s sovereign wealth fund, in early August. 💿 Square Enix has denied a Japanese media report that the company was planning to go private. In very different Square Enix news, the company revealed that the physical version of Final Fantasy VII: Revelation, the April 2027 finale of its radical remakes of FFVII, will include just one disc in its case, requiring a download for the rest. The first two FFVII remakes in the trilogy shipped on two discs apiece. While Square hasn’t commented on the reason why, a feature here in Game File last month broke down the processes and costs for physical games. The expense of a second disc comes out of the game publisher’s cut of each copy. Square could be saving in excess of a dollar a copy with this move. 🟥 Grand Theft Auto IV’s 26-minute ’‘extended look” gameplay showcase that premiered on Netflix last week—and was exclusive to the platform for six hours—drew 31.1 million views in its first four days, the streamer announced. (Netflix calculates views as total viewed hours divided by runtime; excludes replays). Compared to YouTube: The version that later premiered on Rockstar Games’ YouTube channel is sitting at 22.6 million views after seven days (YouTube’s more liberal counting system tallies anyone who viewed even just the first few second.) Compared to other Netflix mega-events: Last year, Stranger Things season 5’s first four episodes, which debuted together, drew a record 59.6 million views in their first few days on Netflix. For more of a live event type of comparison, in 2024, the Jake Paul vs. Mike Tyson boxing match drew 65 million concurrent streams as it happened; Netflix didn’t release live numbers for the GTA premiere. ☁️ Microsoft is changing the way it charges for cloud gaming, from an all-you-can-play offer for Xbox Game Pass subscribers, to caps for the subscription’s tiers (15 hours per month at the Ultimate tier), with the option to buy more hours in bulk beyond that. The company also said it will sell batches of cloud gaming time to non-Game Pass subscribers, details TBA. Microsoft does not release figures for cloud game usage, but said its changes would impact 4% of Game Pass subscribers. That implies a small portion of its subscribers exceed the 15-hour monthly mark. Cloud gaming offers the promise of playing games without the need for console or PC hardware, as the graphics, sound and controls are all transmitted via a streaming connection. Microsoft notes that its cloud gaming service can be used for a range of things, including Xbox One players using it to play newer-gen Xbox Series games via streaming; and people playing games via streaming, sans any console, “in markets where consoles are less available or affordable.” (That latter use case could even be relevant in Xbox’s home market soon, as console prices keep rising.) Take Two Interactive chairman Strauss Zelnick recently told investors he expects game-streaming tech, which has been only lightly adopted by gamers for over a decade, to be widely used within three years. 🇺🇸 The Trump administration has published multiple agenda-driven web video games to the White House’s website. One called Build The Wall partially clones Tetris as it asks players to build a wall to stop a “zombie border siege.” While actual Tetris involves clearing lines and basically not building a wall, the Trump-backed game omits the line-clearing aspect (and omits the fun as well). On Instagram, Tetris’ official license holders reacted by stating: “At Tetris we believe in the power of connection and bringing people together, not dividing them. To our fans everywhere: we love you, we see you, and we’re grateful to have you in our community. P.S. The Tetris Company was not involved in the creation of ‘Build the Wall.’ P.P.S.: We take copyright infringement very seriously.” Item 3: The week ahead: Tuesday, September 8 Game releases: Mewgenics (consoles; already out on PC) is an engrossing tactical combat game (with cats). It is getting its console port right after the release of a Star Wars tactics game and ahead of the late September launch of a Fire Emblem–a bumper crop for the genre. Wanderburg (PC) is an auto-shooting game like Vampire Survivors, but you’re a castle on wheels Event: Nintendo airs a 30-minute Nintendo Direct (10am ET) focused on The Legend of Zelda’s 40th Anniversary. A full unveiling of the upcoming remake of The Legend of Zelda Ocarina of Time is expected. Will they also show footage from next year’s live action movie? Tease the next big 3D Zelda? Add Link to Mario Kart World? Shadow-drop a new Tingle game? Wednesday, September 9 Event: Nintendo again! On this day, they’re planning to air a 45-minute Nintendo Direct (10am ET) focused on games heading to Switch 2 this winter. Followed by about an hour of gameplay demoed by the company’s Treehouse team. The September Nintendo Directs are always some of the year’s biggest. The 2025 edition included announcements of several major 2026 Switch/Switch 2 games: Pokémon Pokopia, Mario Tennis Fever, Yoshi and the Mysterious Book, Fire Emblem Fortune’s Weave. Plus the return of the Virtual Boy. Friday, September 11 Game release: EA Sports NHL 27 (PlayStation, Xbox) is a hockey game. There are so few that an indie studio that had been making wacky sci-fi first-person shooters just announced that, hey, we’re going to fill a void and make a hockey game for PC.
Annual Summer Bazaar Underway in Utica
The annual summer bazaar at Our Lady of Lourdes-Mary, Mother of Our Savior Parish is bringing the community together.
Jim Cramer Notes Cardinal Health (CAH) is “Too Attractive to Ignore”
On the September 2 episode of Mad Money, Jim Cramer called Cardinal Health, Inc. (NYSE:CAH) one of his “absolute favorites” and mentioned its growing exposure to specialty pharmaceuticals and higher-margin healthcare services. Cardinal’s been running circles around McKesson and Cencora. They consistently put up the best numbers because this company has gradually become less of […]
People on the Move: Leo Russo, PhD, Joins Life Science Cares Philadelphia Board of Advisors
Life Science Cares Philadelphia has welcomed Leo Russo, PhD, to its Board of Advisors, bringing more than 25 years of pharmaceutical industry experience in…
From Pandemic Prevention to Pharmaceutical Resilience: Why Health Security Should Be Part of US-Taiwan Economic Security Cooperation
As strategic competition in the Indo-Pacific region intensifies, Washington increasingly views Taiwan as both a reliable partner for democracy and regional stability, and as a critical contributor to supply-chain resilience and technology security. However, one important area has room for improvement: health security and pharmaceutical resilience.
Women in Science: Dr Sabina Auhunas - TIB-Blog
The blog series “Women in Science” introduces women from the TIB who give insights into their careers and personal experiences in science. Dr Sabina Auhunas studied Pharmacy at Bogomolets National Medical University, and obtained her PhD in Pharmaceutical Sciences at Shupyk National Healthcare University of Ukraine in Kyiv and is now working at TIB (Open Science Lab). In this interview, she talks about diversity, shifting directions and persistence in academia.
WATCH: Trump says more pharmaceutical companies will lower drug prices
A winner, a loser, and a mid-stage signal from a major cardiology research conference
The mental health system after Lindsay Clancy, pushing boundaries for new radiopharmaceuticals, and more health news from Morning Rounds
UToledo College of Pharmacy and Pharmaceutical Sciences Welcomes Largest Pharm.D. Class in 5 Years
White Coat Ceremony marks the start of the professional journey for 135 incoming pharmacy and pharmaceutical sciences students.
Health plan in NY deny your claim? Research says keep appealing
For home health care, 78.4% of claims denials taken to the second level of appeals were overturned during tthe study period, researchers found.
Adirondack Railroad Offers Train Rides to Remsen Barn Festival
Adirondack Railroad is offering special round-trip train service from Utica to the Remsen Barn Festival of the Arts, giving festivalgoers a scenic and convenient way to attend the event.
Royal Roots & Rhythms Festival at Hanna Park on Saturday
A festival celebrating culture, heritage and community is set to bring families together in Utica.
Thyroid medication recalled nationwide due to possible ‘superpotency’ issue
A pharmaceutical company is recalling 3,655 thyroid tablets sold nationwide because they could be more potent than usual and may bring about health issues for people who use them.
Moving science out of silos: A conversation with biochemist and philanthropist Mick Hitchcock, Ph.D.
Biochemist Mick Hitchcock reflects on his career in pharmaceutical innovation and his commitment to advancing science and communication at the University of Nevada.
Chuck Stevens named president of RTI Health Solutions
RTI Health Solutions names Chuck Stevens as president, bringing more than 25 years of biopharmaceutical and life sciences leadership experience.
Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026
/PRNewswire/ -- Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a leading clinical-stage biopharmaceutical company focused on cardiovascular diseases, today...
Human creativity still has the edge – and this CEO says an MBA can help you use it
Emerging technologies are changing the face of Australian business, but this pharmaceuticals CEO says there’s still plenty of room for human creativity, if you’ve got the right tools
BioVivo Science launches VeriPalmetto with fully traceable saw palmetto supply chain
The ingredient addresses growing demand for authenticated, US-sourced saw palmetto — with direct harvester relationships, standardised fatty acid profiles and rigorous batch testing to counter adulteration risks in the category
Subnautica 2 Early Access 1.2 Update Out Now Alongside Patch Notes, Dev Donates $100,000 to Ocean Cleanup
Subnautica 2 Early Access 1.2 is out now, adding the Buddy System to the underwater survival and crafting game. check out the patch notes in full.
Subnautica 2 Patch Adds Buddy System, Dev Reveals Glimpse at Early Access 2 Update
Subnautica 2 gets its Buddy system update today, August 19. It adds a number of new features revolving around multiplayer in the underwater survival and crafting game. Here's what to expect from the 1.2 update.
Unknown Worlds / Subnautica 2 Buddy System Update
Subnautica 2’s Early Access 1.2 update, Buddy System, just landed!
Nexira spotlights science-backed solutions for women’s health
Women’s health is expanding through hormone-focused, lifecycle nutrition. At Vitafoods Asia, Nexira launches BloomEase, a science-backed solution combining botanicals and marine magnesium to support premenstrual syndrome and improve women’s comfort and well-being
Opinion: The science that protects our children doesn't take a summer vacation
Connecticut's own biopharmaceutical community has played an important role in advancing vaccine science.
Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
/PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), an oncology-focused biopharmaceutical company and majority-owned...
Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
/PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR), a biopharmaceutical company dedicated to the development and...
Adirondack Railroad to Add 2 Vintage Railcars
Two historic first-class vintage railcars will soon join the Adirondack Railroad fleet, bringing a new experience to train rides through Utica, Old Forge, Tupper Lake and the Adirondack Mountains.
Pace appoints Andy Fenny as president to drive life science growth
Pace, a science and technology company, has appointed Andrew (Andy) Fenny as president of Pace Life Sciences, the organization’s life sciences division, to lead the business into its next phase of strategic growth with a focus on expanding support and capacity for pharmaceutical and biotech clients across the development cycle.
Azitra, Inc. Announces Q2 2026 Results and Provides Business Updates
/PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative...
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Completed underwritten public offering with gross proceeds of $66.0 million and uplisting to the Nasdaq Capital Market, significantly strengthening the...
Advancing the science of dietary nitrate with integrated vascular assessment
Standardised beetroot-derived dietary nitrate supports endothelial function, arterial compliance, central haemodynamics and nitric oxide bioavailability, thereby promoting systems-based research in vascular nutrition
Campbell unites pharmaceutical science, clinical research in future-focused degree
The reimagined bachelor’s program prepares students for careers across the entire drug development lifecycle, with an emphasis on hands-on experience… More on this post
Lallemand Bio-Ingredients to spotlight science-driven ingredients at Vitafoods Asia 2026
Lallemand Bio-Ingredients, Health Ingredients, a global leader in fermented functional ingredients for human health and nutrition, will showcase its latest science-backed ingredients at Vitafoods Asia 2026, taking place September 2-4, 2026, in Bangkok, Thailand
COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance
Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 6.3% year on year to $199.9 million. The company’s full-year revenue guidance of $840 million at the midpoint came in 3.4% below analysts’ estimates. Its non-GAAP profit of $1.92 per share was 8.8% above analysts’ consensus estimates.
The noise is getting louder, which is why science matters more than ever
For brands and formulators in gut health, the rise of AI-generated misinformation makes verified science a commercial differentiator, not just a regulatory safeguard
COLL Q2 Deep Dive: ADHD Expansion and Pain Business Headwinds Shape Guidance
Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 6.3% year on year ...
Procter & Gamble acquires Thorne for $3.8bn in bet on science-backed supplement growth
The deal, expected to close in Q4 2026, brings Thorne's clinically validated, practitioner-trusted supplement portfolio into P&G's consumer health stable — signalling mainstream consumer goods giants' accelerating move into premium VMS
AI generates personalized radiopharmaceutical therapy doses in under 23 seconds
The model has the potential to improve upon the one-size-fits-all dosing approach used for most RPT prostate cancer treatments.
Ocular Therapeutix Reports Second Quarter Revenue, Provides Business Highlights
BEDFORD, Mass.—Ocular Therapeutix, Inc. (NASDAQ: OCUL), an integrated biopharmaceutical company in the retina space, has reported financial results for the second quarter ended June 30, 2026, and provided recent business highlights. Total net revenue was $13.5 million for the second quarter of 2026, flat as compared with the same period in 2025. The company also reported a net loss of $78.8 million for the quarter, compared with a net loss of $67.8 million for the comparable quarter of 2025.
Senate Panel To Examine Biotech's Role in U.S. Health Resilience
Senate Finance Committee investigates biotech's impact on U.S. health resilience as China gains pharmaceutical advantage. Hear expert testimony August 4.
Upstate discount grocery store urges Mamdani to emulate model in NYC
Bargain Grocery in Utica has been run by a nonprofit group and in business for over 20 years.
UConn School of Pharmacy and Pharmaceutical Sciences Professor Xiuling Lu Receives Director Promotion
UConn School of Pharmacy and Pharmaceutical Sciences Professor (SoPPS), Xiuling Lu, was recently announced as the new Director of Research and Graduate Educ ...
Twisted laser light can tell mirror-image molecules apart
Scientists have created twisted laser beams that interact differently with right-handed and left-handed molecules, revealing their identity through the fragments they produce. The approach could provide a faster, simpler, and more sensitive way to analyze important molecules used in chemistry and pharmaceuticals.
KGK Science secures investment to expand nutraceutical clinical research
North American nutraceutical CRO KGK Science will use growth investment from Maxim Partners to expand clinical trials, decentralised research and regulatory services for dietary supplement and consumer health companies
OraCMU oral probiotic gains Health Canada approval
Stratum Nutrition is expanding its clinically researched oral probiotic ingredient OraCMU into Canada after securing a Health Canada product licence
"Stranger Things" Meets the Wrestling Ring in Utica
Fans of the Netflix series "Stranger Things" and professional wrestling will get a unique experience when actor Randy Havens makes an appearance at the Utica University Nexus Center.
Industry and D.C. Are Racing Ahead on Psychedelics. They Should Let Science Lead.
President Trump and pharmaceutical companies are betting big on psychedelics. But hype isn't the same as scientific proof, and urgency must be coupled with caution.
Samsung Biologics: geographic diversification is a sound business decision
Samsung Biologics has been on a steep upward growth trajectory since receiving its first licence to produce biologic drug substances in 2015.
Cardinal Health to buy Strive Medical, AdaptHealth's diabetes health business for $360M
Cardinal Health is pursuing two tuck-in acquisitions to expand its home care business. | The pharmaceuticals and specialty products distributor plans to buy AdaptHealth's diabetes health business unit and medical supply provider Strive Medical in separate deals worth $360 million.
Bristol Myers, NVIDIA join forces to build life science’s ‘most powerful’ AI factory
BMS enhances its AI computing power with NVIDIA's DGX SuperPOD as big pharma race to stay competitive within the shifting global landscape.
Wooly Mammoth startup Colossal seeking at least $20B valuation
Its research could be foundational in pharmaceuticals, climate change reversal, and longevity.
SuanNutra expands natural ingredients portfolio with IFF business acquisition
The nutraceutical ingredients supplier is set to acquire a portfolio of speciality natural ingredients businesses from IFF, creating a global ingredients group spanning branded actives, botanical extracts, fermented nutrients and clean-label food solutions
Bristol Myers Squibb Building Life Science Industry’s Most Advanced AI Factory on NVIDIA Vera Rubin
The pharmaceutical company has demonstrated how AI can transform how drugs discovery and is now scaling AI across R&D to accelerate the discovery of next-generation medicines.
Kaneka pitches “mitoceuticals” as mechanism-led mitochondrial health supplements
Cellular health is becoming increasingly important as industry and science reveal that health systems are interconnected. The mitochondria are especially central in this understanding, as it addresses healthy aging, healthspan, and lifestage demands. Nutrition Insight speaks with Kaneka Corporation and Kaneka Ubiquinol’s consultant to learn about how nutrition is evolving on an industry and consumer level. “Over the past decade, we’ve seen nutrition evolve from addressing nutrient deficiencies to supporting specific conditions and now toward supporting healthspan — the health and well-being across life stages,” says Tsuyoshi Takakuwa, head of Marketing and Sales Team (APAC), Supplemental Nutrition Business Division at Kaneka Corporation.
Delivering Access
There was once a time when you healthcare without mentioning Honeybee Health Inc. In 2019, CNBC listed it as one of the 100 most promising startups. In
Broadway Utica Stage Ready students present Grease
Broadway Utica's Stage Ready Summer Intensive students will perform "GREASE School Edition" on July 24 at Proctor High School. Tickets are on sale now.
Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and AtaiBeckley Inc. (Nasdaq: ATAI), a clinical-stage biopharmaceutical company developing innovative...
Bavarian Festival at Utica Maennerchor in Marcy This Weekend
Preparations are underway for the Bavarian Festival at the Utica Maennerchor, a club on Flanagan Road established by the German community in Utica.
Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business
/PRNewswire/ -- Servier, an independent international pharmaceutical group governed by a foundation, today announced that it has completed the acquisition of...
Pesticide makers stack wins against US environmental, public health groups
The U.S. Supreme Court handed a major legal victory to German agrichemical and pharmaceutical company Bayer last month when it reined in thousands of lawsuits accusing the German company of failing to warn users that glyphosate, the active ingredient in its Roundup weedkiller, causes cancer.
Bioenergy Life Science adopts decentralised clinical research to support nutraceutical claims
The ingredient supplier says real-world decentralised studies can help brands generate finished-product evidence at lower cost while addressing growing regulatory expectations around substantiated health claims
Bayer sells stake in contraceptives business to Apollo in €3bn financing deal
Sale will help German pharmaceuticals group to bolster its balance sheet after years of litigation over Roundup weedkiller
Preparing for Boilermaker Race Day
Thousands of people will come to the City of Utica to participate in the Boilermaker Road Race, making this one of the busiest weeks of preparation.